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Abstract
Reparative medical techniques, in conjunction with existing and emerging tissue
adherents and sealants, offer practicing physicians a wide variety of tools to improve the
functionality, performance, and safety of surgical interventions. Carboxymethylcellulose (CMC)
is a plant-derived polymer that is cytocompatible, biocompatible, biodegradable, and
inexpensive. The need for a non-toxic but strongly adherent material motivated the development
of an injectable bioadhesive system containing CMC modified with functional methacrylate and
aldehyde groups that could potentially be used as an annulus fibrosus sealant or as a supplement
to existing wound closure materials. After modification, the polymer was characterized via NMR
spectroscopy, Schiff’s base reaction, and size exclusion chromatography with multi-angle light
scattering (SEC-MALS). The adhesive strength of the material was determined by lap shear
testing with porcine skin.
High molecular weight and medium molecular weight methacrylated dialdehyde
carboxymethylcellulose (MeDCMCHV & MeDCMCMV) were engineered and MeDCMCHV was
combined with low viscosity methacrylated CMC (MeCMCLV1) to produce an adhesive
hydrogel. The percent oxidation and methacrylation was measured to be 21.1 ± .84 % and 49.0%
for MeDCMCHV2. The percent methacrylation of MeCMCLV1 was determined to be 30.6%.
Various ratios of MeDCMCHV to MeCMCLV were tested via lap shear testing and the best
combination possessed a shear adhesive strength of 6.022 ± 1.456 kPa. The dispersity index (Đ)
was calculated to be 1.93 for MeDCMCHV and 2.94 for MeDCMCMV. The creation of an
adhesive from MeDCMCHV will provide a foundation for the development of cellulose-based
annulus fibrosus sealant with stronger adhesive strength and highly tunable properties such as
swelling-ratio, pore size, and degradation profile.
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Chapter 1 - Introduction
1.1 Repairing Intervertebral Disc Injury
The intervertebral disc (IVD) is a tissue located between the vertebral bodies of the spine,
keeping them spaced within a tolerant range. It is composed of two macroscopic regions, the
nucleus pulposus (NP), and the annulus fibrosus (AF)1. The viscous, gelatinous structure of the
NP allows it to bear large compressive loads through pressurization and transfer of the load to
the AF and cartilaginous endplate (CEP)2,3. The NP matrix is composed of four constituents,
water, collagen, proteoglycans and cells. The AF surrounds the NP with multiple cross-ply
laminated structures with anywhere from 10 to 25 lamellae and is composed of water, collagen,
proteoglycans, and cells. Degeneration of the annulus fibrosus due to aging and the presence of
advanced glycation end-products lead to a change in the anisotropic and nonlinear behaviors of
the tissue in compression, resulting in an increase in the elastic modulus in compression and a
decrease in tensile strength in stretch4,5. The loss of CEP integrity also leads to the loss of NP
pressurization and the unsustainable shift of compressive load bearing from the NP to the AF6.
In the general population the prevalence of lower back pain is estimated to be 15% to
30% with individuals 45 to 65 years of age being at the greatest risk7,8. Discogenic back pain is
pain that arises from the degeneration or disc injury. The treatment of discogenic back pain often
involves techniques which are highly invasive including lumbar fusion and discectomy, which
are often successful in alleviating the pain associated with pathologies of the IVD9–11. The
treatments for back pain that exist today do not tackle the restoration of biomechanical properties
of the IVD after injury. In discectomy in particular, when the NP material is removed, the
compressive load on the IVD is transferred to the AF resulting in abnormal loading which
increases the possibility for more annular defects, re-herniation, and pain12. An annular defect via
needle puncture was shown to have a drastic impact on the maximum strain of AF fibers in
5

locations near and away from the site of injury as demonstrated by the strain map in Figure 1-1.
Therapies being explored have shown that biomaterials may be used to replace damaged or
missing NP material14–17. In addition to materials for NP replacement, a suitable AF replacement
or sealant should be explored. A cellulose-based bioadhesive/sealant may provide the adhesion

Figure 1-1. (Left) Strain map of control, (Right) Strain map of needle punctured
sample with white arrows indicating areas of increased strain13.
and cohesion suitable for the containment of native NP tissue or engineered NP replacement
technologies.

1.2 Surgical Practice
Hemostats, sealants, and adhesives are gaining popularity and acceptance in surgical
practice in the United States as a means of achieving maximal wound closure. A hemostat is a
surgical tool or a chemical agent at the disposal of a surgeon to stop bleeding through mechanical
compression or blood coagulation. Tissue sealants create an impenetrable barrier sealing the
tissue. Adhesives are self-polymerizing solutions that adhere to tissues. Surgical glues and
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hemostats are used in order to create a mechanical barrier where there is bleeding present and
help to enhance coagulation18. In 2009 there were 10 million surgical and nonsurgical cosmetic
procedures performed, 2.5 million of which were botulinum toxin injections and 1.3 million
hyaluronic acid filler injections19. While 85% of the cosmetic procedures performed are nonsurgical, there is still a market for cosmetic and non-cosmetic surgeries requiring wound closure.
Outcomes of patients requiring wound closure are dependent on wound infection, restoration of
function, and optimal cosmetic results20. As government regulators, hospital administrations, and
patients desire more minimally invasive procedures, engineering solutions are in demand to help
promote the restoration of mechanical and cosmetic properties of tissues and minimizing blood
loss21.

1.2 Sutures, staples, and adhesive strips
Sutures have been used for millennia as a means of closing wounds. Recent technological
innovations have increased their effectiveness22. When selecting the ideal suture it is important to
consider the age of the patient, the location of the wound, the presence or absence of infection,
and the surgeon’s personal experience and preference of materials, as some materials are more
difficult to handle than others23. The physical characteristics include their method of absorption,
composition, configuration, and surface topology. Suture absorption is defined as the loss of
most of its tensile strength within 60 days of tissue implantation22. Material compositions range
from natural materials like Catgut, derived from cow or sheep intestinal submucosa and silk22–24,
to synthetic materials including nylon, polypropylene, poly(glycol terephthalate), and
poly(butylene terephthalate); each of these materials having a unique tissue reactivity, tensile
strength, and handling22,23. While sutures are the gold standard of wound closure, they present
cosmetic issues because the intact surrounding tissue is subject to damage. Surface stitch
7

configuration and the type of surface stitch plays a role in the amount of scarring that occurs as a
result of the wound and the suture22,23. The use of sutures after annular repair has been shown to
decrease the rate of disc degeneration as well as promote the restoration of biomechanical
properties, however, AF replacement technologies still need to be explored that help reverse disc
degeneration and improve the mechanical function of the intact AF tissue25,26.Skin staples are
primarily important because they can be applied to a wound quickly. They are ejected from a
device which significantly reduces the time required to fully close the wound and they are
sometimes used to temporarily position skin edges together before suturing23. Staples come in
primarily two materials, a non-absorbable stainless steel, the highest tensile strength wound
closure material, and an absorbable u-shaped material of primarily of poly(lactide) and a
secondary component of poly(glycolide). Absorbable sutures retain 40% of their strength at 14
days and completely absorb over the course of months23. The biggest disadvantage of using
sutures and staples is that they have to be sewn in which creates damage to the tissue requiring
closure.
Adhesive strips are often used in conjunction with sutures or other closure materials
because they help maintain the integrity of the epidermis which results in less tension to the
wound and sutures23. They are also used in the retention of wound closure after the removal of
sutures. Adhesive strips suffer from the lack of tissue integration as they do not adhere or do not
remain intact in moist areas, areas of high movement, and areas of high tension making them
unsuitable for a wide variety of applications18. Biomaterials being explored must be easy to use,
rapid, painless, cost effective, and provide excellent comesis23.
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Chapter 2 –Clinically Available Materials for Wound Closure
2.1 FDA-Approved Adhesive Materials
The Food and Drug Administration (FDA) has approved many materials for use as
hemostats, sealants, adhesives, and postoperative adhesion prevention agents. These materials
include synthetic polymers, human and bovine-derived polymers, and plant-based polymers21.
Many biomaterials have been exhaustively studied and thus can be a benchmark for performance
as well as a means of determining what characteristics are desirable for biomaterials to be
developed for AF repair.

2.2 PEG Sealants
Biosynthetic materials derived from synthetic polymers have been functionalized with
biological constituents in a manner that optimizes them for biomedical implantation. Coseal
(Baxter, Fremont California) is a mixture of multifunctional polyethylene glycol (PEG)
macromers contained in an aqueous hydrogen chloride and sodium phosphate-sodium carbonate
solution. Coseal is used to mechanically seal areas of leakage around blood vessels. Coseal
swells up to 400 percent which introduces increased risk for complications in closed spaces27,28.
Duraseal Xact (Covidien, Mansfield, MA), a modified version of a previously FDA-approved
synthetic spinal sealant Duraseal (Coviden), has been recently approved by the FDA21. This
material is used in conjunction with sutures in dural repair to create a watertight seal of the dural
matter, reducing the risk of cerebrospinal fluid (CSF) leak and inhibiting the formation of scar
tissue29. This material consists of a PEG polymer with tri-lysine amine as well as FD&C blue
No. 1 dye in order to demarcate boundaries and assist the surgeon with placement18. The lower
molecular weight of the PEG in Duraseal Xact reduces the swelling to reduce the possibility of
nerve compression. Duraseal Xact has been shown to swell from 50 to 100 percent, a significant
9

improvement over Duraseal, but still presents the possibility for complications due to
swelling18,28. Rapid polymerization of this material also reduces the risk of CSF leakage after
surgery, thereby increasing the overall safety and effectiveness of the product30,31.

2.3 Fibrin-based sealants
FDA-approved Tisseel (Baxter, Westlake Village, CA), Evicel (Johnson& Johnson), and
the CryoSeal systems (ThermoGenesis Corp., Rancho Cordova, CA) are commercially available
fibrin sealants that are used in various hemostatic, sealant and adhesive capacities21,32.
Commercial agents like Tisseel contains elements that prolong and ensure the stability of the clot
such as the serine protease inhibitor aprotinin, which works to limit the degradative effects of
plasmin, kallikrein, and trypsin33. The benefits of fibrin-based sealants are that they quickly cure,
are biocompatible, and biodegradable. Fibrin-based sealants like Tisseel and Evicel are derived
from human pooled plasma fibrinogen and thrombin, which introduces the possibility of
transferring blood borne diseases including human immunodeficiency virus, hepatitis, parvovirus
B19, as well as prions34,35. Manufacturers have employed multiple strategies in order to reduce
the risk of disease transmission including donor screening, testing, and pathogen reduction
strategies. In the last 20 years there are no reports of HIV or hepatitis transmission as a result of
fibrin based sealants, however, there is documentation of the transmission of parvovirus B19 as a
result of fibrin sealants35,36. The CryoSeal system has circumvented the risk of contracting
diseases from allogeneic plasma pools through the production of an automated device that
produces several units of fibrin sealant from 450 ml of the patient’s blood preoperative
preparation.37 While fibrin sealants and adhesives may be biocompatible and commonly used in
surgical practice, their relatively low adhesion to tissue make them a poor choice for true
bioadhesive applications such as for AF repair38. Additionally, the risk of host enzyme
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degradation makes fibrin-based sealants unlikely for use in long-term applications such as an AF
sealant.

2.4 Cyanoacrylate-based sealants and adhesives
Omnex (Ethicon, Inc., Somerville, NJ), a cyanoacrylate-based synthetic surgical sealant,
is composed of a mixture of 2-octyl cyanoacrylate and butyl lactoyl cyanoacrylate39. This
material is used as a supplement to mechanical closure techniques such as sutures and staples.
Generally, cyanoacrylates are not approved for internal use. However, the Omnex formulation
proposes that the release of the formaldehyde degradation product occurs in a slow and safe
manner over the course of 36 months as to not pose a major risk for cytotoxicity21. While
cyanoacrylate-based sealants may be strongly adhesive in the surgical setting there is great risk
for injury to the tissue and contamination through adhesion with surgical tools, gloves, and nonintended tissue targets especially if the surgeon is unable to properly control the application of
this polymer21. Therefore, biomaterials must be explored that meet adhesive requirements but do
not pose a great risk for injury in the event of surgeon error.
The FDA has approved multiple cyanoacrylate based adhesives which include
Dermabond (Johnson & Johnson, Somerville, NJ) Indermil (Covidien, Norwalk, CT) and two
formulations Histoacryl and Hystoacryl Blue (Tissueseal, Ann Arbor, MI)18. These materials
have been approved for use as an additive to traditional surgical skin closure methods like
sutures and staples to keep the edges of skin together. The exothermic nature of the reaction as
well as the toxicity of the degradation products, specifically cyanoacetates and formaldehyde,
restricts its internal use34. Therefore, such adhesives are unlikely to serve as candidate materials
for AF repair. When used in wound closures, to limit adverse reactions from heat sensitivity and
discomfort, only thin layers are applied34. Additionally, the site of wound closure is of great
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importance with cyanoacrylate-based adhesives as they are extremely adhesive and extremely
stiff. These products are not approved for use in areas of high tension, across joints, on mucosal
surfaces, at mucocutaneous junction or on areas of dense hair growth18.

2.5 Albumin and Glutaraldehyde based adhesives
Bioglue (Cryolife, Kennesaw, GA) is a serum albumin and glutaraldehyde mixture that is
approved for vascular sealing. The glutaraldehyde cross-links with the amine groups, specifically
the lysines of albumin and tissue surfaces, creating a tightly cross-linked adhesive18. Safety
concerns have arisen due to potential nerve conduction system injury from glutaraldehyde, local
tissue necrosis, mutagenicity, abnormalities in calcium metabolism, disease transmission; eye,
nose, throat, and skin irritation18. Glutaraldehyde has been shown to induce cytotoxic effects in
vitro and in vivo, specifically in lung and liver tissue28,40.
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Chapter 3 – Experimental Materials for Bioadhesion
As many of the currently FDA-approved materials have been shown to be either
ineffective in adhesion or deemed to toxic for internal use, many research groups are exploring
the possibility of modifying materials for the purpose of making them bioadhesive and
biocompatible. Through the exploration of mechanisms of adhesion as well as material cohesion,
biomaterials can be tailored to meet the properties of the tissues of interest.
3.1 Protein and Polysaccharide-Based Materials for Bioadhesion
Oxidized polysaccharide-based bioadhesives have been investigated in order to address
some of the disadvantages and limitations of commercially available bioadhesives. These
materials include but are not limited to dextran41–43, alginate44,45, and chondroitin sulfate46.
Oxidized polysaccharides have been chosen as materials for bioadhesives because they are
generally biocompatible, biodegradable, and exhibit superior adhesion strength when compared
to commercially available non-glutaraldehyde/cyanoacrylate based bioadhesives. The oxidation
level of the material determines the number of aldehyde groups created and thus the maximum
adhesive strength of the material can be adjusted to fit specific tissues based on the required
adhesion strength and protein density. The mechanism by which aldehydes create bonds with
proteins is through the Schiff base reaction with the terminal ends of proteins or the basic ɛamino of lysine (demonstrated in Figure 3-1). Given that mammalian skin is a collagenous tissue

+
ɛ-amino of lysine or
Schiff base linkage
terminal amino acid
Figure 3-1. Schiff Base Formation with Aldehyde and ɛ-amino of Lysine

Aldehyde
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more than 50% of the amino acids occurring in the proteins are glycine and
proline/hydroxyproline47. Mammalian skin is composed of 2.9 ± 0.4% lysine and thus its
relatively low availability makes it a target for attachment because an adhesive will not
overwhelm the tissue with crosslinks.
One downside of increased oxidation is the increased degradation which can lead to the
loss of mechanical properties. Oxidation levels can be tailored to maximize adhesion and to
control the rate of polymer degradation. Bioadhesives must not only be capable of adhering
strongly but also degrading in such a manner that is beneficial to the healing process. Adhesion
is a balance between different types of molecular interactions including hydrophilic/hydrophobic
interactions, ionic interactions, and covalent and hydrogen bonding48. The modification of
polysaccharides allows for the creation of materials that can optimize these interactions for
bioadhesive applications.
Oxidized urethanized dextran has been proposed as a tissue adhesive when used in
conjunction with gelatin and polymethacrylate. The study by Wang, Nie, and Yang showed that
varying the degree of oxidation affected the swelling kinetics, swelling ratio, and adhesion
strength in a photocrosslinked hydrogel41. Additionally a tissue adhesive based on oxidized
dextran and epsilon-poly-l-lysine was shown to be 13 times more adhesive in tensile shear than
the fibrin-based glue Bolheal43. Powdered aldehyde dextran and epsilon-poly (L-lysine) and
carboxymethylchitosan/oxidized dextran hydrogels have been investigated as an antipostoperative adhesion material and has been shown to decrease the severity of adhesions in a rat
peritoneal injury model49,50.
Hydrogel systems have been fabricated using oxidized methacrylated alginate and 8-arm
poly(ethylene glycol) amine (OMA/PEG)45. The oxidation of the alginate component created
dialdehydes distributed along the alginate chains and the methacrylate groups were introduced to
14

allow for photocrosslinking capabilities. By having a dual crosslinking mechanism the polymer
was able to crosslink via imine bonds between the aldehyde groups and amines on the PEG and
tissue, in addition to covalently crosslinking methacrylate groups in the presence of a
photoinitiator. When mechanically tested via a pull apart test and this OMA/PEG hydrogel
exhibited a mean adhesive strength of 15kPa, which is approximately five times stronger than the
commercially available fibrin sealant Tisseal45.
Multifunctional chondroitin sulfate (CS) adhesives have been explored for potential
cartilage tissue biomaterial integration46. CS was multifunctionalized with methacrylate and
aldehyde groups through glycidyl methacrylate and sodium periodate oxidation. The basis of the
creation of this material was the need for a material that allows for cartilage tissue integration.
This engineered material was proposed as a means of priming the surface of a tissue so that a
non-oxidized methacrylated poly (ethylene glycol) diacrylate hydrogel could be used as a
cartilage tissue replacement. The hydrogel-interface adhesive strength was tested in uniaxial
tensile and horizontal shear with and without the CS primer solution. With the CS primer, the
tensile strength was 45 kPa and 2.8 kPa without. With the CS primer, the shear strength was 46
kPa, and 6.0 kPa without, showing that bioadhesives are capable of optimizing existing strategies
for tissue engineering46.
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Fibrin-Genipin hydrogels have also been engineered as a means of repairing large AF
defects in herniation and disc repair51,52. Genipin is a plant-derived crosslinking agent that
crosslinking proteins by binding amine groups51. Genipin crosslinked fibrin hydrogels were
shown to integrate well into the surrounding AF tissue as seen in Figure 3-2 and partially restore
mechanical properties of injured intervertebral disc motion segments, showing that biomaterials
may play a key role in the delivery of relief in those suffering with discogenic back pain52.

Figure 3-2. Repair of annular injury with Fibrin-Genipin hydrogel52

3.2 Cellulosic Materials
Polysaccharide-based hydrogel systems are being explored for a wide variety of tissue
engineering applications. One family of polymers of great interest is celluloses, specifically
carboxymethylcellulose (CMC) and methylcellulose (MC), which are water-soluble derivatives
16

of cellulose, the primary structural component of the plant cell wall. CMC and MC are non-toxic,
biodegradable, inexpensive, and used in a wide variety of industries including food, textiles,
paper, adhesives, paints, pharmaceutics, and cosmetics53. Previous work pertaining to the
creation and the characterization of CMC-based hydrogels for applications in nucleus pulposus
cell encapsulation for NP replacement has demonstrated that cellulose may be a suitable material
for NP replacment54,55. Through the esterification of hydroxyl groups to add methacrylate groups
to the cellulose backbone and by varying the molecular weight of the CMC polymer, hydrogels
have been previously constructed with tunable properties such as stiffness, pore size, and
swelling ratio. Cellulose is desirable for in vivo applications because cellulose is not readily
enzymatically degraded, as cellulase is not present in humans. Covalently crosslinked CMC
hydrogels have been shown to support the differentiation of a wide variety of cells in vitro
including human fibroblasts, mesenchymal stem cells55, as well as nucleus pulposus cells14. At
low temperature methylcellulose is more water soluble, when the temperature is increased over
35°C a thermoreversible gel is formed which increases the interaction of the polymer chains as a
result of hydrophobic interaction56. Given its ability to thermally gel, methylcellulose may be

Figure 3-3. Methylcellulose or Carboxymethylcellulose Backbone
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used in crosslinked hydrogels as a means of increasing solution viscosity and localizing material
within a void space.
The periodate oxidation of cellulosic materials has been used industrially for various
applications 57. The cleavage of the C2-C3 bond of the 1-4 glucan unit produces a dialdehyde
which can then be used as intermediates for functionalized cellulose-based materials for tissue
engineering, drug delivery, or any number of applications unrelated to medicine. Additionally
these aldehydes can be converted to carboxylic acids, primary alcohols or imines with primary
imines58. Polysaccharides containing aldehydes are being explored as bioadhesives because the
aldehydes can form imine bonds with amines through the Schiff base reaction and bond to the
surface of tissues42,43,59. The material aldehyde density can be tuned to match the tissue protein
density such that cytotoxic effects, if any, are limited59. Polysaccharides that have been oxidized
to the dialdehyde form are more readily susceptible to alkaline β-elimination and thus hydrolytic
degradation60–63. By varying the degree of oxidation and methacrylation of the polymer the
degradation can be tuned to a manner that facilitates the retention of wound closure as well as
wound healing.
Oxidized regenerated cellulose (ORC), an absorbable knitted fabric that is flexible and
adheres readily to bleeding surfaces, has been used as a barrier agent for the prevention of
adhesion formation64. The mechanism of action is thought to be the transformation of the knitted
cellulose into a gelatinous mass that covers the injured tissue and protects the tissue from the
formation of adhesions64. These data suggest that a hydrogel composed of oxidized cellulose
may be a suitable agent for the prevention of postoperative adhesions.
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3.3 Redox-Crosslinked Hydrogels
Many materials being explored for potential bioadhesive applications have been
employed photocrosslinking as a means of initiating hydrogel polymerization. Recently,
injectable CMC and MC hydrogel systems have been investigated that use redox initiators rather
than photo initiated polymerization as a method to increase the clinical translatability of the
materials65,66. When human dermal fibroblasts were co-cultured with MeCMC and MeMC gels
polymerized via redox initiators ammonium persulfate (APS) and N, N, N’, N’tetramethylethylenediamine (TEMED) at 10 mM concentration, there was no significant effect
on the proliferation and viability of these cells at 10 mM initiator concentration65,66.
Additionally, APS and TEMED at concentrations of 25 mM have been shown to support cell
viability and proliferation in an oligo(poly(ethylene glycol) fumarate) scaffold with encapsulated
rabbit marrow mesenchymal stem cells and transforming growth factor-1 incorporated into
gelatin microparticles67.
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Chapter 4 - Proposal
4.1 Rationale
As there is strong evidence that polysaccharide-based materials may be suitable for
bioadhesive applications such as for AF repair, injectable oxidized CMC hydrogels will be
investigated as an adhesive and sealant, given that CMC is cytocompatible, biocompatible,
biodegradable, inexpensive, and proven to work in an injectable system.

4.2 Hypothesis
CMC can be modified via oxidation and a subsequent methacrylation to produce an
injectable hydrogel that has tunable adhesive properties by varying the concentration of polymer.

4.3 Proposal
Dual-modified CMC will be synthesized by the sodium periodate oxidation of CMC and
the esterification of hydroxyl groups to add methacrylate groups to dialdehyde CMC (DCMC).
Methacrylated dialdehyde CMC (MeDCMC) will be polymerized via redox initiation to produce
covalently crosslinked hydrogels. The degrees of methacrylation and oxidation will be
quantitatively determined via 1H-NMR spectroscopy and sodium hydroxide consumption after
Schiff base reaction, respectively. The dispersity of the material will be characterized via Size
Exclusion Chromatography-Multi Angle Light Scattering (SEC-MALS). Characterization of
adhesive strength will be quantified via lap shear pull-apart test with porcine epidermis as a
model for collagenous soft tissues, such as the AF. In addition, tests on porcine epidermis allow
for direct comparison of the measured adhesive strength of dual-modified CMC with values of
existing materials used for skin closure described in the literature.
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Chapter 5 - Methods & Materials
5.1 Preparation of Oxidized CMC
In early experiments involving 250 kDa medium viscosity CMC (CMCMV) (Sigma, St.
Louis, MO) and 700 kDa high viscosity CMC (CMCHV) (Sigma), the unmodified polymer was
dissolved in DI water to a final solution concentration of approximately 1% to allow for better
mixing compared to 2% solutions. It was determined that the final solution concentration of 1%
or 2% did not have a significant impact on the degree of oxidation. To prepare DCMC, 10 grams
of CMC-sodium salt was slowly dissolved in 600 ml of deionized water at 50°C for two hours
and stirred overnight at 4°C. The following day the beaker was wrapped in aluminum foil and
the solution was heated to 35°C. Concurrently, 11 grams of sodium periodate (Sigma) was
dissolved in 400 ml of diH2O in the dark and the periodate solution was added to the CMC. The
pH of the solution was then adjusted to 3.0 using 1M sulfuric acid and allowed to stir in the dark
for four hours at 35°C while slightly adjusting the pH to 3.0 as needed using sulfuric acid and
sodium hydroxide. Special precaution was taken to perform the reaction in the dark because
periodate solutions exposed to light slowly decompose as a result of the auto-reduction of
aqueous sodium periodate to form ozone and iodate68. After four hours, the oxidation reaction
was terminated by the addition of ethanol at a 2:1 molar ratio of the initial concentration of
sodium periodate. The reaction mixture was dialyzed for 3 days against diH2O. The mixture was
then frozen and lyophilized for 3 days until the product was dry. Samples were stored in the
freezer at -20C. The frozen product was then used in later experiments with MeCMCLV1
(synthesized from low viscosity, 90 kDa CMC starting material) or subsequently used to produce
MeDCMC.
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Figure 5-1. Periodate Oxidation of CMC to DCMC

5.2 Preparation of Methacrylated Celluloses
Preliminary experiments involving the oxidation of CMCMV showed that conditions that
reported high yields in aldehyde content (40-50% oxidation) also yielded a product that was
visually broken down and mechanically inferior as the material did not gel at a redox initiator
concentration of 25 mM at weight per volume (w/v) percentages upwards of 20%. Therefore, a
CMC with a larger molecular weight was chosen as the starting polymer with the basis that a
larger molecule would produce larger fragments in response to dual modification. To prepare
MeDCMC, lyophilized DCMCHV was dissolved in DI water to final concentration of 2%. Two
reaction times were chosen, a one-day, 8-hour short reaction and an extended three-day reaction,
to compare the effect of methacrylation on the adhesive strength of the material. CMCLV or
DCMCMV,HV was reacted with methacrylic anhydride in 20-fold excess for a theoretical
methacrylation of 10% at 4°C while adjusting the pH every 3 to 15 minutes to 8.0 with 5N
NaOH for 7-8 hours for the short one-day methacrylation. For extended methacrylation
reactions, the same procedure was followed except the addition of methacrylic anhydride was
extended over the course of three days with pH adjustments to 8.0 for 10 hours on the first day, a
second day in the refrigerator at 4°C with no pH adjustments, and pH adjustment to 8.0 for 8
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hours for the third day at 4°C. Once the reaction was finished, the pH was adjusted to 7.0 with
1N HCl. The solutions were dialyzed against diH2O for 3 days and lyophilized for 3 days.
Samples were stored in the freezer at -20°C.
The degree of methacrylation was assessed via 1H-Nuclear Magnetic Resonance (NMR)
spectroscopy at 500 MHz (Varian Mercury 500, Agilent Technologies). Samples were prepared
for NMR spectroscopy by dissolving 0.02 g of lyophilized MeDCMC in 20 ml of DI water. The
solution was then acid hydrolyzed in a round bottom flask by adjusting the pH 2.0 using 1N HCl
and magnetically stirring the mixture in an 80°C silicone oil bath at 200 rpm for 140 minutes.
The solution was allowed to cool to room temperature then adjusted to pH 7.0 with 1N NaOH
and subsequently frozen at -80C and lyophilized for three days. After lyophilization the material
was dissolved in D2O and NMR spectroscopy was performed.

+
Figure 5-2. Synthesis of Methacrylated Dialdehyde Carboxymethylcellulose

5.3 Determination of aldehyde content
The aldehyde content was determined by converting DCMC or MeDCMC to an oxime
via the Schiff’s base reaction with hydroxylamine hydrochloride as carried out by Li et al53. The
Schiff’s base reaction was carried out by dissolving three portions of DCMC or MeDCMC
weighing 0.25 g in separate beakers containing 12.5 ml of diH2O. In parallel, 40 ml of a solution
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of 0.72 mol/L hydroxylamine hydrochloride (HAHC) was prepared and all the solutions were
adjusted to pH 5 with 1M NaOH or 1M HCl. After pH adjustment, 10 ml of the HAHC solution
was added to each of the DCMC solutions and the mixture was stirred for 4 hours in a
thermostatic water bath at 40°C. After 4 hours the samples were immediately titrated with 1M
NaOH for the release of HCl until the pH was adjusted to 5. The amount of NaOH required in
liters was recorded as Vc. The same procedure was performed in triplicates of 12.5 ml of a 2%
solution of CMC and the amount of NaOH consumed by the CMC solution to pH 5 was recorded
as Vb. The following formula was subsequently used to determine the aldehyde content in
DCMC.
𝑨𝒍𝒅𝒆𝒉𝒚𝒅𝒆 𝑪𝒐𝒏𝒕𝒆𝒏𝒕 =

𝑴𝑵𝒂𝑶𝑯 (𝑽𝒄 − 𝑽𝒃 )/𝟐
× 𝟏𝟎𝟎%
𝒎/𝟐𝟏𝟏

Equation 1
In Equation 1, 𝑴𝑵𝒂𝑶𝑯 is the Molarity of the sodium hydroxide solution, m is the mass of
the oxidized material used and 211 g/mol is the average molecular weight of the repeating unit.
The equation is divided by a factor of two because a dialdehyde is created when the repeating
unit is modified.

5.4 Hydrogel formulation
When tested for gelation, the MeDCMC reacted for one day was unable to polymerize
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Figure 5-3. Double Barrel Syringe with Mixing Tip

when mixed with MeCMCLV1, therefore all subsequent batches were methacrylated for three
days. MeDCMC and MeCMC were weighed out and placed in both barrels of a double barrel
syringe. An appropriate amount of 1X Dulbecco’s phosphate-buffered saline (DPBS)
(Invitrogen) was added to each barrel to bring the solution to the proper concentration, and the
solution was manually stirred with a metal rod and dissolved at 37°C for several hours with
intermittent mixing to obtain a homogenous maximally dissolved solution. The solutions were
stirred immediately after preparation and placed on ice in a 4°C refrigerator overnight. The next
day the redox initiators APS (25 mM) (Sigma-Aldrich) and TEMED (25 mM) (Sigma-Aldrich)
were added to separate barrels, well incorporated to the viscous solutions via stirring, and heated
to 37°C in a water bath for approximately 30 minutes to 1 hour until the lap shear testing
samples were prepared. A mixer tip was then attached to the double barrel apparatus and the
sample was extruded for mechanical testing.

5.5 Lap Shear Testing
Lap shear tests are commonly used as a method of determining the adhesive strength for
materials that bond biological tissues 41,69. In this study, porcine dermis was chosen as the
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Figure 5-4. Custom built PVC casting devices

biological substrate for adhesion because of its uniformity and availability. Porcine tissue,
excised from the back of the animal, was purchased from a local market. The samples were
manually cleaned of all fatty tissue leaving only the residual dermal tissue and they were frozen
at 20°C. Frozen samples were cut into 8mm in diameter rounds using a biopsy punch and
samples were thawed and placed in a 1XPBS solution (Sigma) overnight. Strips of sandpaper
approximately 3.5 cm in length and 1cm width were cut and the porcine dermis was glued via
Loctite Super Glue (Henkel Corp., Rocky Hill, CT). The use of sandpaper assured that the
adhesive was only capable of adhering the porcine skin and only the defined contact area. The
use of strips of overlapped porcine skin in pilot studies resulted in non-uniformities with regards
to contact area, thus a circular construct with a non-biological backing was chosen. The porcine
samples were then glued to the smoother paper side of the sandpaper with the epidermis facing
up and the contact area was photographed using a stereomicroscope prior to testing. The samples
were then placed in PVC casting device and one strip was secured via a clamp. The polymer
solution was then applied to the porcine skin and the other round of skin on the sandpaper strip
was precisely placed over the first to maximize contact area and clamped down to ensure that the
layers did not move. The samples were then placed in a humidified incubator at 37°C and
allowed to cure for one hour. Adhesion was assessed by a lap shear test using an Instron Series
5543 (Canton, MA) equipped with a 10N load cell. The upper grip moved upwards at a speed of
5 mm/min at room temperature to measure the adhesive shear strength (Figure 5-6). Studies
involving experimental bioadhesives used crosshead speeds ranging from 5 mm/min to
10mm/min41,43,48. Additionally, preliminary testing with dual-modified CMC showed that a
crosshead speed 5mm/min was suitable for the measurement of the adhesive strength. The
samples were loaded until failure and 8 samples were used for each formulation. All of the
materials synthesized were tested to see if they were inherently adhesive and in combinations
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which are shown in Figure 5-5. The combinations were tested in various ratios to try to optimize
injectability and gelation.

Sample
CMCMV

CMCMV
CMCMV

DCMC MV

DCMCHV

MeCMC LV

MeCMC MV

MeDCMC MV

MeDCMC HV

DCMCMV
DCMCHV
MeCMC LV
MeCMC MV
MeDCMC MV
MeDCMC HV

Not Tested
Not Tested
Not Tested
Not Tested
Not Tested
Not Tested

DCMCMV
Not Tested
Tested
Not Tested
Not Tested
Not Tested

DCMCHV
Tested
Not Tested
Not Tested
Not Tested

MeCMCLV
Not Tested
Tested
Tested

MeCMCMV
Not Tested
Tested

MeDCMCMV
Not Tested

MeDCMCHV

Figure 5-5. Formulations of CMC Investigated

Figure 5-6. Sample before (left) and after (right) shear adhesive testing at a head speed of
5mm/min
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5.6 Size Exclusion Chromatography - Multi-Angle Light Scattering (SEC-MALS) Sample
Preparation
SEC-MALS experiments were carried out using a DAWN HELEOS MALS detector
(Wyatt Technology, Santa Barbara, USA) with a laser wavelength of 658.0 nm. To prepare
samples for SEC-MALS 10 ml of a 1g/L solution of MeDCMC was dissolved in 100 mMol/L
solution of sodium chloride as carried out by Hoogendam et al70. Previous experiments involving
SEC-MALS showed that CMC in pure diH2O was interacting with the column, thus the addition
of a 100 mMol/L solution of sodium chloride as the eluent showed that the solvent was suitable
for the SEC. The injection loop volume was 100 µl and the volumetric flow rate was 1mL/min.
Data acquisition and analysis was performed using Astra Version 5.3.4.20. The dispersity index
(Đ) is the measure of how uniformly distributed the molecular masses are within a sample71.
Dispersity is the ratio of the weight average molecular weight to the number-average molecular
weight as shown in Equation 2.

Đ𝑴 =

𝑴𝒘
𝑴𝒏

Equation 2
5.7 Statistical Analysis
A one-way ANOVA with a Tukey’s post-hoc test was used to determine the effect of the
ratio of MeDCMC to MeCMC on the adhesive shear strength (P < 0.05). Data represent the
mean ± STD.
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Chapter 6 : Results and Discussion
6.1 Characterization of CMC derivatives
MeDCMCMV and MeDCMCHV were synthesized via the oxidation of the C2, C3 bond
and the esterification of unreacted hydroxyl groups with methacrylic anhydride. Representative
NMR spectra of MeDCMC (Figure 6-1. & Figure 6-2.) and MeCMC (Figure 6-3.) samples show
the characteristic methacrylate peaks (methyl peak at 1.9 ppm and methylene peaks at 5.8 & 6.2
ppm) and the characteristic aldehyde peak (9.0 ppm). The methacrylation percentage of the
MeDCMCHV2 sample used in the lap shear testing study was determined to be ~ 49% and the
methacrylation of the MeCMCLV1 was determined to be ~ 31%. The methacrylation percentage
was calculated by comparing the relative area of the methyl peak and the area of the backbone
peak to their respective number of hydrogens (Equation 3).

( 𝑀𝑒𝑡ℎ𝑦𝑙 𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎)/(# 𝑜𝑓 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑖𝑛 𝑀𝑒𝑡ℎ𝑦𝑙)
𝑥100 = % 𝑀𝑜𝑑𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛
(𝐵𝑎𝑐𝑘𝑏𝑜𝑛𝑒 𝐴𝑟𝑒𝑎)/(# 𝑜𝑓 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑖𝑛 𝑏𝑎𝑐𝑘𝑏𝑜𝑛𝑒)

Equation 3

A high degree of methacrylation is necessary, as increased methacrylation decreases the
gelation time and increases the cohesive potential of the material. Given the high degree of
methacrylation, the material should have formed gels at concentrations upwards of 1% if the
molecular weight of the polymer was unchanged. However, later studies involving the
characterization of the Đ and Mw of the MeDCMC via SEC-MALS showed the presence of
drastically degraded polymer that may have impeded the formation of cohesive gels. This result
was most likely due to random chain scission via sodium periodate and the β-elimination during
the methacrylation reaction in alkaline conditions60–63.
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Figure 6-1. NMR Spectrum of MeDCMCMV2

Figure 6-2. NMR Spectrum of MeDCMCHV2
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Figure 6-3. NMR Spectrum of MeCMCLV1
6.2 Determination of Aldehyde Content
Previously, sodium periodate oxidized batches of CMCMV resulted in oxidation
percentages over 40% (MeDCMCMV2). While it was the intention to maximize the oxidation to
achieve maximal adhesion with the least amount of polymer, it resulted in a polymer that was
mechanically compromised. This assessment was made visually and via manual manipulation of
the material. Thus, for experiments involving adhesive testing, the high molecular weight
polymer was chosen as the starting material, as it was thought to be sufficiently large enough to
withstand the degradative effects of the oxidation and methacrylation process, and retain a
fraction of polymer with a large molecular weight. Additionally, ethanol was added to quench
the later reactions in order to ensure that the sodium periodate was inactivated. This ethanol
quenching was not performed on the MeDCMCMV2 material and the results show that these two
actions resulted in a significantly less oxidized polymer (20%, as assessed by Schiff base
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titration). Future studies involving the dual modification of CMC should investigate how
prolonged methacrylation and oxidation reactions affect the molecular weight of the product
such that the proper steps can be taken to reduce the degradation of the polymer and optimize the
purification and homogeneity of the polymer. One step that can be taken immediately is the use
of a larger molecular weight cutoff for dialysis. The molecular weight cutoff for the dialysis
tubing used in all of these reactions was 6-8 kDa, which may retain a significant amount of the
oxidized polymer but contribute to a non-uniform highly polydisperse sample. The gelation rate
of a polymer is contingent on the mobility of the polymer and the entanglement density in
solution72. The formation of a 3D network is therefore highly dependent on the dispersity of a
material. The presence of smaller the fragments may lower the probability of interchain
association, thereby decreasing the rate of gel formation. Pilot studies involving porcine samples
incubated for 24 hours showed that gel formation eventually occurred but the time elapsed did
not meet the criteria for a material to be a clinically relevant bioadhesive.

6.3 Analysis of Adhesive Strength
Various solutions were tested to show how the various ratios of dual-modified CMC and
methacrylated CMC affected the adhesive strength of the material. Over the course of developing

Sample
CMCMV
DCMCMV
DCMCHV
MeCMCLV
MeCMCMV
MeDCMCMV
MeDCMCHV

CMCMV

DCMCMV

DCMCHV

MeCMCLV MeCMCMV MeDCMCMV MeDCMCHV

CMCMV
Not Tested
Not Tested
Not Tested
Not Tested
Not Tested
Not Tested

DCMCMV
Not Tested
Failed
Not Tested
Not Tested
Not Tested

DCMCHV
Failed
Not Tested
Not Tested
Not Tested

MeCMCLV
Not Tested MeCMCMV
Failed
Not Tested MeDCMCMV
Success
Success*
Not Tested MeDCMCHV

Figure 6-4 Table of all combinations tested *Unable to surpass Instron threshold for measurement (Qualitative
Assessment)
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these materials, different combinations were explored at various ratios for adhesivity, including
DCMC alone, MeCMC + DCMC, MeDCMC + MeCMC, and MeCMC. No material alone was
sufficiently adhesive to attach to tissues. The only combination of materials that was able to
form an adhesive gel was MeDCMCHV +MeCMCLV. MeDCMCHV + MeCMCMV was strong
enough to load materials for testing, however, the material did not reach the minimum force
threshold for accurate measurement on the Instron.
The rationale for creating the MeDCMCHV-MeCMCLV mix was based on the idea that
MeCMC would serve to increase the cohesion of the gels and the MeDCMC would act as the
adhesive agent with the potentially cohesive functionality, capable of binding to the MeCMC,
MeDCMC, and the tissue. The first solution was made at 30% MeDCMC and 7.5% MeDCMC
and the remaining solutions were 40% solutions with varying ratios of MeDCMC to MeCMC as
seen in Table 6.1.

Solution

MeDCMCHV2 % (w/v) MeCMCLV1 % (w/v)

Total Polymer % (w/v)

Shear Tensile Strength Pa
(STD)

4:1 Mix

30

7.5

37.5 4423 ± (1310)

3:1 Mix

30

10

40 4465 ± (1477)

5:3 Mix

25

15

40 6022 ± (1456)

1:1 Mix

20

20

40 2971 ± (1351)

3:5 Mix

15

25

40 2206 ± (1114)

Table 6-1. Compositons of MeDCMC-MeCMC Solutions
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b *
b

b
a
a

$

Figure 6-5. Adhesive strength of selected ratios of MeDCMC to MeCMC.
Significance set at p<0.05. * significantly different than a. $ significantly different than b.
There was a clear decrease in the mixibility and injectability of the material as the
percentage of MeDCMC increased. A 30 mg/mL solution of MeDCMCHV2 alone could be easily
mixed and injected, however, the inability to polymerize at a 25 mM initator concentration in the
allotted time of 1 hour, and the inability to remain localized at the injection site led to the
addition of MeCMCLV1. The adjustment of the MeDCMCHV2 concentration to 25% w/v and
addition of MeCMCLV1 at 15% w/v in the 5:3 mix led to a polymer that had the highest mean
adhesion strength of 6.02 ±1.46 kPa compared to the other solutions, especially the 1:1 and 3:5
mix. According to the literature, fibrin-based sealants in lap shear adhesive tests with porcine
epidermis produced similar values of approximately 3-8 kPa45,73. It is worth noting that unlike
most adhesives, the samples failed cohesively and not at the tissue-adhesive interface. This
suggests that a more cohesive material should be able to increase the adhesive shear strength of
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the material, and that this experiment likely measured the cohesive ability of these materials
instead of the true adhesive capacity. The range of adhesive shear strengths of commerically
available materials on porcine skin range from the 3 kPa in the fibrin-based adhesive Tisseel45 to
200 kPa with the cyanoacrylate-based adhesive, Dermabond. The 1:1 and 3:5 mix solutions were
extremely difficult to extrude through the mixing tip and gelled extremely quickly, therefore,
further studies should not incorporate such viscous material at such a high concentration. Due to
the gross amount of material needed to run each combination and the limited amount of time to
complete the project, we were unable to test other combinations. The 49% methacrylation of the
MeDCMCHV and the 31% methacrylation of the MeCMCLV mostly likely played a role in the
cohesion, however, the lack of gelation of MeDCMC is an issue that must be addressed in future
studies.

6.4 Determination of Mw by SEC-MALS
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Figure 6-6. Raw light scattering and Molar mass as a function
of time as determined by SEC-MALS
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100 mMol/L were determined using a dn/dc value of 0.156 which is an number based on
literature that previously characterized solutions of CMC of varying degrees of substitution70,74.
A use of a 100 mMol/L aqueous solution of NaCl as the solvent was show to be suitable for the
determination of molecular weights of CMC and MeDCMC. There is a clear trend in the
distribution of molar masses in samples that double-modified polymer compared to the
unmodified CMC. Based on the nature of the elution curve (light scattering) in Figure 6-6a,b,
unmodified CMC is monodisperse as it has smaller range of molar masses in comparison to
MeDCMCMV2 & MeDCMCHV2 in Figure 6-6c,d, which have elution curves with a long tail and a
wider distribution of molecular masses. The confirmation of these fragments via molar mass
distribution analyses in Figure 6-7 and Figure 6-8 support the hypothesis that the dispersity of
these materials were greatly affected by the dual modification process. Figure 6-9 and Figure 610 show the molar mass distribution between two molecular weights of MeDCMC. The molar
mass weight fraction of MeDCMCMV2 shows that only 35.37% of the molecules are larger than
50 kDa, which is significantly less when compared to the 64.49% of the molecular weight
greater than 50 kDa retained by MeDCMCHV2. This reinforces the idea that further steps can be
taken to purify MeDCMCHV such that it is monodisperse without a severe loss in the overall
yield of the reaction. Given that the molecular weight of the largest molecules that eluted from
each sample were larger than the advertised molecular weight of the material, this suggests the
formation of aggregates, which may affect the true distribution of the molecular weight. The
presence of these aggregates also introduces error into the calculation of Đ (Table 6-2). To help
reduce the formation of aggregates, the solutions may be prepared under constant agitation as to
detangle and prevent the formation of aggregates. The sodium chloride and polymer
concentration in solution also play a major role in aggregate formation; therefore, it is necessary
to test these parameters in the future.
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Figure 6-7. Molar Mass Distribution Analysis of Unmodified Low Viscosity CMC

Figure 6-8. Molar Mass Distribution Analysis of Unmodified High Viscosity CMC
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Figure 6-9. Molar Mass Distribution Analysis of MeDCMCMV2

Figure 6-10. Molar Mass Distribution Analysis of MeDCMCHV2
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Material

Mw (g/mol)

Mn (g/mol)

Dispersity Index (Đ)

CMCLV

2.2510E+05

1.4830E+05

1.52

CMCHV

1.0130E+06

8.9160E+05

1.14

MeDCMCMV

1.0670E+05

3.6270E+04

2.94

MeDCMCHV

1.0840E+05

5.6060E+04

1.93

Table 6-2. Calculated values of Mw, Mn, and the resulting Đ. The Đ of MeDCMCMV was
significantly higher than all of the other materials, as predicted by the visual assessment of the
lyophilized polymer and the shape of the elution curve.
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Conclusions
Dual-modified carboxymethylcellulose was created via sodium periodate oxidation and
the esterification of hydroxyl groups to add methacrylate groups. The Schiff Base reaction with
hydroxylamine hydrochloride and titration of HCl with NaOH was used to assess the percent
oxidation. The successful addition of methacrylate groups was assessed via NMR spectroscopy.
The inability of MeDCMC to form a cohesive gel led to the addition of a methacrylated low
viscosity CMC as a cohering agent. Various ratios of MeDCMCHV to MeCMCLV were tested and
the lap shear adhesive strength was affected by the ratio of MeDCMCHV to MeCMCLV. In order
to understand how dual modification of the polymer was affected, SEC-MALS was performed to
determine the molecular weight distribution. The results showed that the molecular weight of
CMC was significantly affected by the dual modification, which mostly likely produced the
inferior gelation capability. Gelation optimization will vastly improve the ability for MeDCMC
to seal an AF defect. Qualitative studies with robustly gelling solutions of MeDCMC
polymerized with 250 mM redox initiator concentration showed that the adhesive potential on
porcine skin was substantial. However this initiator concentration is likely to cause damage to
nearby cells and tissues.
CMC shows promise as a base material for bioadhesive applications because of its ability
to be readily oxidized and methacrylated. The suggestions for the optimization of the dispersity
should increase the likelihood that a monodisperse material can be extracted from the reaction,
which increases the likelihood of the development of an adhesive that can form a cohesive
material without the addition of MeCMC. Given the susceptibility of oxidized cellulose to
alkaline β-elimination, there may be a valid argument for reversing the order of the reactions and
oxidizing CMC after methacrylation. The methacrylation of CMC is optimal in basic conditions
and requires a total of 5-6 days in water, which may result in severe degradation to the backbone.
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The addition of a peptide such as poly (l-lysine) could be beneficial to the formation of a
cohesive material that has a dual-crosslinking mechanism. Having two means of crosslinking
should also allow for lower macromer concentrations, and thus improve the injectability of the
material and its likelihood as an AF sealant.
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Future Directions
Future work concerning the development of a bioadhesive using MeDCMC will require
the optimization of the protocol. By extending the time for dialysis against diH2O as well as
using a larger molecular weight cutoff we can decrease the polydispersity of the material leading
to a more uniform material with more predictable gelation characteristics. Additionally,
cytotoxicity studies should be performed in order to observe the cellular response to the aldehyde
moieties on the CMC backbone. Cytotoxicity studies should involve the cellular response to
encapsulation as well as indirect and direct contact. Once the material is monodisperse,
degradation studies should also be performed to see how crosslinked hydrogels composed of
MeDCMC degrade compared to solutions of MeCMC of similar molecular weight and
methacrylation. A one-component system consisting of solely MeDCMC is ideal because it
introduces fewer variables. However, the addition of MeCMC may serve to dilute the adhesive
effects of a highly oxidized polymer, and a highly methacrylated formulation could further
increase the cohesive strength of the material. Swelling tests should also be conducted to
determine the response of the material to an aqueous environment, in vitro and in vivo, once the
material is deemed cytocompatible.
The degree of oxidation of CMC via sodium periodate can be altered by the sodium
periodate concentration, the length of the reaction, and the use of an alcohol to quench the
reaction. Therefore, future studies should investigate how a lengthened reaction time can affect
the dispersity and the degree of oxidation of CMC. The creation of a single component, 50%
oxidized MeDCMC bioadhesive will most likely lead to the improvement of shear adhesive
strength and cohesiveness. The cohesiveness of the material can be assessed visually by
observing if the adhesives mechanically fail at the tissue or internally. The cohesiveness can also
be assessed via measuring the tensile strength in response to stretch. Additionally, this material
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should be tested as a sealant when used in conjunction with a MeCMC hydrogels for NP
replacement. First, a push-out test should be performed with a circular defect in annular tissue to
determine if the material is able to properly integrate into the AF, and secondly, a tissue explant
model using bovine caudal discs under dynamic loading should be employed to determine if
MeDCMC is capable of containing engineered NP material within the disc space under
physiological loading conditions. Comparison to commercially available sealants and biological
glues under identical testing conditions would also be necessary to confirm the utility of this
novel, cellulose-based adhesive.
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